Gracell taken over in the US by AstraZeneca for $1.2b usd.
these things can happen quick once the data rolls in.
CHM have the team and look to have the treatments to achieve this or more.
deals are happening and in the Car-t space. I’m looking forward to an exciting 2024 for CHM.
a deal for CHM1101 is the first cab off the rank but who knows the exact timing . My guess is Merck will be interested if phase1b results look as good as the phase 1a.
can’t wait for the final phase 1a data read out.
just remember the results can be impressive and the market may not notice but BP will know what’s up
watched Gracell make great announcements and sp didn’t respond.
once they presented at ASCO sp started to rise and bang takeover
Gracell taken over in the US by AstraZeneca for $1.2b usd.these...
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
-0.001(4.17%) |
Mkt cap ! $19.69M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.3¢ | $15.85K | 674.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 516660 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 402773 | 3 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.3¢ |
Change
-0.001 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 2.3¢ | 2.3¢ | 2.3¢ | 206248 | ||
| Last updated 12.16pm 21/05/2024 ? | |||||
| CHM (ASX) Chart |